Pharmacielo Ltd (PCLO) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.236x

Based on the latest financial reports, Pharmacielo Ltd (PCLO) has a cash flow conversion efficiency ratio of 0.236x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-3.53 Million ≈ $-2.55 Million USD) by net assets (CA$-14.94 Million ≈ $-10.81 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see PCLO company net worth for the company's overall valuation and market capitalisation.

Pharmacielo Ltd - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Pharmacielo Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Pharmacielo Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Pharmacielo Ltd ranked by their cash flow conversion efficiency. See cash flow to debt ratio of Pharmacielo Ltd to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
DGB Group NV AS:DGB	0.235x
Longvie SA BA:LONG	-0.060x
Bell Copper Corp V:BCU	-0.066x
Home Pottery Public Company Limited BK:HPT	0.010x
TNF Pharmaceuticals, Inc. NASDAQ:TNFA	-0.178x
Corella Resources Ltd AU:CR9	-0.129x
Micro Digital Co. Ltd KQ:305090	-0.143x
ATAM VALVES ORD (BSE) NSE:ATAM	0.009x

Annual Cash Flow Conversion Efficiency for Pharmacielo Ltd (2016–2024)

The table below shows the annual cash flow conversion efficiency of Pharmacielo Ltd from 2016 to 2024. View current stock price of Pharmacielo Ltd for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CA$-7.52 Million ≈ $-5.44 Million	CA$-1.97 Million ≈ $-1.42 Million	0.262x	-91.45%
2023-12-31	CA$-1.68 Million ≈ $-1.22 Million	CA$-5.15 Million ≈ $-3.73 Million	3.066x	+301.87%
2022-12-31	CA$6.39 Million ≈ $4.62 Million	CA$-9.71 Million ≈ $-7.02 Million	-1.519x	-46.22%
2021-12-31	CA$19.33 Million ≈ $13.98 Million	CA$-20.07 Million ≈ $-14.52 Million	-1.039x	-20.82%
2020-12-31	CA$26.25 Million ≈ $18.99 Million	CA$-22.56 Million ≈ $-16.32 Million	-0.860x	-55.33%
2019-12-31	CA$45.47 Million ≈ $32.89 Million	CA$-25.16 Million ≈ $-18.20 Million	-0.553x	-30.88%
2018-12-31	CA$185.55K ≈ $134.23K	CA$-78.47K ≈ $-56.76K	-0.423x	+98.98%
2017-12-31	CA$91.02K ≈ $65.84K	CA$-3.79 Million ≈ $-2.74 Million	-41.637x	-12744.15%
2016-12-31	CA$9.57 Million ≈ $6.92 Million	CA$-3.10 Million ≈ $-2.24 Million	-0.324x	--

About Pharmacielo Ltd

V:PCLO Canada Drug Manufacturers - Specialty & Generic

Market Cap

$6.80 Million

CA$9.40 Million CAD

Market Cap Rank

#28053 Global

#1217 in Canada

Share Price

CA$0.05

Change (1 day)

-16.67%

52-Week Range

CA$0.04 - CA$0.14

All Time High

CA$11.02